Wedbush Upbeat On Vitae Pharmaceuticals Despite Diabetes Results

By: via Benzinga
Vitae Pharmaceuticals Inc (NASDAQ: VTAE) fell about 15 percent Monday after the company posted disappointing interim results from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.